Cytisin amidophosphate - The new cytoprotector

Zhaxybay Zhumadilov, Talgat Nurgozhin, Alexandr Gulyaev, Sabira Zhaugasheva, Arystan Gazaliyev, Bakytgul Ermekbayeva, Guinara Abuova, Almas Kenessary

Research output: Contribution to journalArticle

Abstract

This article describes the results of a clinical study of O, O dimethyl-N-cytinizylphosphate in healthy volunteers and 142 patients with the verified diagnosis of acute toxic hepatitis. The tolerability was good. The efficiency of the drug is considered to be very high, normalization of the state took less time in comparison with standard treatment; a significant improvement was achieved immediately after the first injection.

Original languageEnglish
Pages (from-to)45-49
Number of pages5
JournalHiroshima Journal of Medical Sciences
Volume61
Issue number3
Publication statusPublished - Sep 2012

Fingerprint

Chemical and Drug Induced Liver Injury
Healthy Volunteers
Injections
Pharmaceutical Preparations
Therapeutics
O,O dimethyl-N-cytinizylphosphate
Clinical Studies

Keywords

  • Acute toxic hepatitis
  • Cytoprotector

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Zhumadilov, Z., Nurgozhin, T., Gulyaev, A., Zhaugasheva, S., Gazaliyev, A., Ermekbayeva, B., ... Kenessary, A. (2012). Cytisin amidophosphate - The new cytoprotector. Hiroshima Journal of Medical Sciences, 61(3), 45-49.

Cytisin amidophosphate - The new cytoprotector. / Zhumadilov, Zhaxybay; Nurgozhin, Talgat; Gulyaev, Alexandr; Zhaugasheva, Sabira; Gazaliyev, Arystan; Ermekbayeva, Bakytgul; Abuova, Guinara; Kenessary, Almas.

In: Hiroshima Journal of Medical Sciences, Vol. 61, No. 3, 09.2012, p. 45-49.

Research output: Contribution to journalArticle

Zhumadilov, Z, Nurgozhin, T, Gulyaev, A, Zhaugasheva, S, Gazaliyev, A, Ermekbayeva, B, Abuova, G & Kenessary, A 2012, 'Cytisin amidophosphate - The new cytoprotector', Hiroshima Journal of Medical Sciences, vol. 61, no. 3, pp. 45-49.
Zhumadilov Z, Nurgozhin T, Gulyaev A, Zhaugasheva S, Gazaliyev A, Ermekbayeva B et al. Cytisin amidophosphate - The new cytoprotector. Hiroshima Journal of Medical Sciences. 2012 Sep;61(3):45-49.
Zhumadilov, Zhaxybay ; Nurgozhin, Talgat ; Gulyaev, Alexandr ; Zhaugasheva, Sabira ; Gazaliyev, Arystan ; Ermekbayeva, Bakytgul ; Abuova, Guinara ; Kenessary, Almas. / Cytisin amidophosphate - The new cytoprotector. In: Hiroshima Journal of Medical Sciences. 2012 ; Vol. 61, No. 3. pp. 45-49.
@article{eda6606723a64458b06ac1c73aa2b048,
title = "Cytisin amidophosphate - The new cytoprotector",
abstract = "This article describes the results of a clinical study of O, O dimethyl-N-cytinizylphosphate in healthy volunteers and 142 patients with the verified diagnosis of acute toxic hepatitis. The tolerability was good. The efficiency of the drug is considered to be very high, normalization of the state took less time in comparison with standard treatment; a significant improvement was achieved immediately after the first injection.",
keywords = "Acute toxic hepatitis, Cytoprotector",
author = "Zhaxybay Zhumadilov and Talgat Nurgozhin and Alexandr Gulyaev and Sabira Zhaugasheva and Arystan Gazaliyev and Bakytgul Ermekbayeva and Guinara Abuova and Almas Kenessary",
year = "2012",
month = "9",
language = "English",
volume = "61",
pages = "45--49",
journal = "Hiroshima Journal of Medical Sciences",
issn = "0018-2052",
publisher = "Hiroshima University School of Medicine",
number = "3",

}

TY - JOUR

T1 - Cytisin amidophosphate - The new cytoprotector

AU - Zhumadilov, Zhaxybay

AU - Nurgozhin, Talgat

AU - Gulyaev, Alexandr

AU - Zhaugasheva, Sabira

AU - Gazaliyev, Arystan

AU - Ermekbayeva, Bakytgul

AU - Abuova, Guinara

AU - Kenessary, Almas

PY - 2012/9

Y1 - 2012/9

N2 - This article describes the results of a clinical study of O, O dimethyl-N-cytinizylphosphate in healthy volunteers and 142 patients with the verified diagnosis of acute toxic hepatitis. The tolerability was good. The efficiency of the drug is considered to be very high, normalization of the state took less time in comparison with standard treatment; a significant improvement was achieved immediately after the first injection.

AB - This article describes the results of a clinical study of O, O dimethyl-N-cytinizylphosphate in healthy volunteers and 142 patients with the verified diagnosis of acute toxic hepatitis. The tolerability was good. The efficiency of the drug is considered to be very high, normalization of the state took less time in comparison with standard treatment; a significant improvement was achieved immediately after the first injection.

KW - Acute toxic hepatitis

KW - Cytoprotector

UR - http://www.scopus.com/inward/record.url?scp=84867672675&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867672675&partnerID=8YFLogxK

M3 - Article

C2 - 23077862

AN - SCOPUS:84867672675

VL - 61

SP - 45

EP - 49

JO - Hiroshima Journal of Medical Sciences

JF - Hiroshima Journal of Medical Sciences

SN - 0018-2052

IS - 3

ER -